Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Baas

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
Dementia and Geriatric Cognitive Disorders|May 27, 2011
Polymorphisms in the catechol-o-methyltransferase gene and delirium in the elderlyBarbara C van Munster, Frank Baas, Michael W Tanck, et al.
Neurogenetics|November 1, 2011
Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebriPepijn van den Munckhof, Imke Christiaans, Susan B Kenter, et al.
Journal of Alzheimer'S Disease : JAD|November 30, 2011
Rab6 is a modulator of the unfolded protein response: implications for Alzheimer's diseaseHyung Lim Elfrink, Rob Zwart, María L Cavanillas, et al.
Neurobiology of Disease|December 16, 2014
Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortexEleonora Aronica, Frank Baas, Anand Iyer, et al.
Cytogenetic and Genome Research|November 16, 2016
Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human OsteosarcomaJoeri Both, Thijs Wu, Anneloor L M A Ten Asbroek, et al.
Molecular Biosystems|July 16, 2009
Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmerKees Fluiter, Olaf R F Mook, Jeroen Vreijling, et al.
Acta Neuropathologica|April 18, 2014
Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumorsTheo J M Hulsebos, Susan Kenter, Wim I M Verhagen, et al.
Journal of Child Neurology|September 15, 2016
Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement DisorderLeonie A Menke, Marc Engelen, Mariel Alders, et al.
Artificial DNA, PNA & XNA|June 21, 2011
In vivo efficacy and off-target effects of locked nucleic acid (LNA) and unlocked nucleic acid (UNA) modified siRNA and small internally segmented interfering RNA (sisiRNA) in mice bearing human tumor xenograftsOrf Mook, Jeroen Vreijling, Suzy L Wengel, et al.
Pharmacogenetics and Genomics|November 7, 2008
Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorderHenricus G Ruhé, Wendy Ooteman, Jan Booij, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
Dementia and Geriatric Cognitive Disorders|May 27, 2011
Polymorphisms in the catechol-o-methyltransferase gene and delirium in the elderlyBarbara C van Munster, Frank Baas, Michael W Tanck, et al.
Neurogenetics|November 1, 2011
Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebriPepijn van den Munckhof, Imke Christiaans, Susan B Kenter, et al.
Journal of Alzheimer'S Disease : JAD|November 30, 2011
Rab6 is a modulator of the unfolded protein response: implications for Alzheimer's diseaseHyung Lim Elfrink, Rob Zwart, María L Cavanillas, et al.
Neurobiology of Disease|December 16, 2014
Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortexEleonora Aronica, Frank Baas, Anand Iyer, et al.
Cytogenetic and Genome Research|November 16, 2016
Oncogenic Properties of Candidate Oncogenes in Chromosome Region 17p11.2p12 in Human OsteosarcomaJoeri Both, Thijs Wu, Anneloor L M A Ten Asbroek, et al.
Molecular Biosystems|July 16, 2009
Filling the gap in LNA antisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4'-C-hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmerKees Fluiter, Olaf R F Mook, Jeroen Vreijling, et al.
Acta Neuropathologica|April 18, 2014
Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumorsTheo J M Hulsebos, Susan Kenter, Wim I M Verhagen, et al.
Journal of Child Neurology|September 15, 2016
Recurrent GNAO1 Mutations Associated With Developmental Delay and a Movement DisorderLeonie A Menke, Marc Engelen, Mariel Alders, et al.
Artificial DNA, PNA & XNA|June 21, 2011
In vivo efficacy and off-target effects of locked nucleic acid (LNA) and unlocked nucleic acid (UNA) modified siRNA and small internally segmented interfering RNA (sisiRNA) in mice bearing human tumor xenograftsOrf Mook, Jeroen Vreijling, Suzy L Wengel, et al.
Pharmacogenetics and Genomics|November 7, 2008
Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorderHenricus G Ruhé, Wendy Ooteman, Jan Booij, et al.
Pageof 24